Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Early androgen exposure affects hormone receptor expression in adult female rats' brains, but not in males.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

The seed extract of Lepidium sativum L. can potentially treat hair loss, showing effects similar to 5% minoxidil.